According to researchers, much of the controversy has to do with product development outpacing the science. Regulatory agencies have simply been unable to keep up.
What are some of the inaccuracies? Some products tested have been found to contain THC, in one study up to 60% of the products tested, even though products were labeled as THC-free. Other products do not contain as much CBD as they claim. Others contain much more.
Furthermore, some products make therapeutic claims not FDA approved. Their misleading claims include relief from a wide range of ailments including pain and wrinkles. This is especially prevalent in topicals.
Researchers also agree that more clinical studies need to be performed as to whether topical products with THC can produce psychoactive effects, get users high, or result in a positive drug test.
It’s also important to note that only one product containing CBD has been approved by the FDA, to date. Epidiolex contains purified CBD, which has been approved for treating seizures associated with two syndromes as linked to severe forms of epilepsy. That said, not everyone can take the drug, as some patients have had to stop taking it due to liver problems.
Furthermore, the FDA has stated that neither THC nor CBD can be marketed or sold as dietary supplements.
Bottom line, anyone who is interested in taking cannabinoids for medical issues should always consult with their health care provider first.
Sources: UPI, Health Day, JAMA Network, National Center for Complimentary and Integrative Health
